Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech
19 nov. 2018 07h00 HE
|
Immunocore Limited
PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech First-in-human clinical trial of IMC-C103C scheduled to commence in 2019 in multiple...
TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
05 juin 2018 08h30 HE
|
TESARO, Inc.
WALTHAM, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with...
California Life Sciences Association (CLSA) Adds Leaders from Genentech, Sanford Burnham Prebys Medical Discovery Institute and OncoCyte to Board of Directors
23 nov. 2015 08h06 HE
|
California Life Sciences Association
SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), today announced that its board of directors appointed three new members: William...
Former Roche Pharmaceuticals CEO Joins Mesoblast Board of Directors
05 mars 2014 19h24 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, March 5, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that William M. Burns, former Chief...
Dr. Napoleone Ferrara Joins the New Scientific Advisory Board of Protelica Incorporated
10 sept. 2013 06h30 HE
|
Protelica, Inc.
HAYWARD, Calif., Sept. 10, 2013 (GLOBE NEWSWIRE) -- Dr. Napoleone Ferrara, a world renowned authority on angiogenesis, and the developer of the anti-cancer drug Avastin has joined Protelica's newly...
Singularity University Announces New Corporate Partnership With Genentech to Explore the Future of Exponentially Advancing Technologies
06 févr. 2012 13h10 HE
|
Singularity University
MOUNTAIN VIEW, Calif., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Singularity University (SU), the only educational institution uniquely focused on the impact and opportunities presented by exponentially...